XML 25 R14.htm IDEA: XBRL DOCUMENT

Note 6 - Goodwill and Intangible Assets, Net

3 Months Ended

Jun. 30, 2024

Notes to Financial Statements

Goodwill and Intangible Assets Disclosure [Text Block]

Note 6. Goodwill and Intangible Assets, Net

Finite-lived intangible assets consisted of the following:

		*June 30, 2024*												*March 31, 2024*
		*Gross Carrying Amount*				*Accumulated Amortization*				*Net Carrying Amount*				*Gross Carrying Amount*				*Accumulated Amortization*				*Net Carrying Amount*
Customer relationships		$	189,708			$	(107,470	)		$	82,238			$	189,911			$	(104,528	)		$	85,383
Other intangibles			61,140				(33,919	)			27,221				61,161				(32,792	)			28,369
Total finite-lived intangible assets		$	250,848			$	(141,389	)		$	109,459			$	251,072			$	(137,320	)		$	113,752

Amortization expense for finite-lived intangible assets was as follows:

		*Three Months Ended June 30,*
		*2024*				*2023*
Amortization in cost of revenues		$	647			$	1,728
Amortization in general and administrative			3,414				5,492
Total amortization expense		$	4,061			$	7,220

For the following fiscal years ending March 31, amortization expense is estimated as follows:

Fiscal Year		*Amortization Expense*
Fiscal Year		*Amortization Expense*
Remainder of 2025		$	13,289
2026			16,975
2027			16,319
2028			15,731
2029			15,182

The change in the carrying amount of goodwill was as follows:

		*Sterilization and Disinfection Control*				*Clinical Genomics*				*Biopharmaceutical Development*				*Calibration Solutions*				*Total*
March 31, 2024		$	79,430			$	16,940			$	46,515			$	37,211				180,096
Effect of foreign currency translation			(494	)			(24	)			150				(6	)			(374	)
June 30, 2024		$	78,936			$	16,916			$	46,665			$	37,205			$	179,722